Report
Age Normalized Testosterone Peaks at Series B for Male Startup Founders
| العنوان: | Age Normalized Testosterone Peaks at Series B for Male Startup Founders |
|---|---|
| المؤلفون: | Moradian, Jordan, Dubrovsky, Michael, Sama, Megha, Korecky, Pavel, Kulkarni, Sidarth, Goder, Yaniv, Vermeulen, Diedrik |
| سنة النشر: | 2024 |
| المجموعة: | Quantitative Finance |
| مصطلحات موضوعية: | Economics - General Economics |
| الوصف: | In a study of 107 male Y Combinator founders, a surprising correlation between age-normalized testosterone and company stage was uncovered. Testosterone, a hormone associated with confidence, dominance, and drive, increased by 55.7% from pre-seed to seed funding, peaking at the Series B stage, where levels were 99.6% higher than pre-seed. After series B funding, testosterone was observed to drop by 42.2%, coinciding with a spike in cortisol levels. This age-normalized biomarker analysis supports the dual-hormone hypothesis, illustrating that early startup success fosters feelings of dominance and confidence, while later-stage pressures and stresses erode these feelings. An alternative interpretation of the data, which suggests the opportunity for a longitudinal study, is that male founders with higher testosterone are more likely to raise larger rounds of funding. Comment: 9 pages, 4 figures |
| نوع الوثيقة: | Working Paper |
| URL الوصول: | http://arxiv.org/abs/2411.03361 |
| رقم الانضمام: | edsarx.2411.03361 |
| قاعدة البيانات: | arXiv |
| الوصف غير متاح. |